Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥18.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥30.1bnat 2023-09-30Cons.Assets
Total assets¥29.0bnat 2023-03-31Cons.Assets
Total assets¥27.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥22.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥551m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥500m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.272023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥214.782022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio72.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 505
ItemContextValueUnit
Other noiPrior1YTDDuration22975000JPY
Other noiCurrentYTDDuration27621000JPY
Non operating incomePrior1YTDDuration83407000JPY
Non operating incomeCurrentYTDDuration99236000JPY
Interest expenses noePrior1YTDDuration548000JPY
Interest expenses noeCurrentYTDDuration1640000JPY
Depreciation of assets for rent noePrior1YTDDuration7526000JPY
Depreciation of assets for rent noeCurrentYTDDuration7217000JPY
Provision of allowance for doubtful accounts noePrior1YTDDuration-JPY
Provision of allowance for doubtful accounts noeCurrentYTDDuration300000JPY
Loss on insurance cancellation noePrior1YTDDuration-JPY
Loss on insurance cancellation noeCurrentYTDDuration4758000JPY
Other noePrior1YTDDuration1163000JPY
Other noeCurrentYTDDuration6824000JPY
Non operating expensesPrior1YTDDuration9237000JPY
Non operating expensesCurrentYTDDuration20741000JPY
Ordinary incomePrior1YTDDuration1294983000JPY
Ordinary incomeCurrentYTDDuration1764686000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration628000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration2012000JPY
Gain on sales of investment securities eiPrior1YTDDuration-JPY
Gain on sales of investment securities eiCurrentYTDDuration22327000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration28720000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration-JPY
Gain on reversal of office transfer expenses eiPrior1YTDDuration-JPY
Gain on reversal of office transfer expenses eiCurrentYTDDuration1829000JPY
Extraordinary incomePrior1YTDDuration29348000JPY
Extraordinary incomeCurrentYTDDuration26168000JPY
Income before income taxesPrior1YTDDuration1324331000JPY
Income before income taxesCurrentYTDDuration1790855000JPY
Income taxes currentPrior1YTDDuration312530000JPY
Income taxes currentCurrentYTDDuration587988000JPY
Income taxes deferredPrior1YTDDuration85535000JPY
Income taxes deferredCurrentYTDDuration-25201000JPY
Income taxesPrior1YTDDuration398065000JPY
Income taxesCurrentYTDDuration562787000JPY
Profit lossPrior1YTDDuration926266000JPY
Profit lossCurrentYTDDuration1228068000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration78453000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration34155000JPY
Profit loss attributable to owners of parentPrior1YTDDuration847812000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1193912000JPY
Profit lossPrior1YTDDuration926266000JPY
Profit lossCurrentYTDDuration1228068000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration149000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration22638000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration118228000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration134495000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration665000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration406000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass